New Analysis of SOLOIST-WHF Results Demonstrates
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30 and 90 Days Following...
Stay updated with breaking news from Bertram Pitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30 and 90 Days Following...
Patients with CKD and type 2 diabetes, who have higher risks of pneumonia and severe COVID-19, might benefit from finerenone.
Secondary analyses from 13,026 people with type 2 diabetes and CKD in the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity.
New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure
Data presented at the Heart Failure Society of America annual scientific meetingNew analysis adds to growing body of evidence in support of the use of...